Literature DB >> 17762629

Recent developments in fluorescence cystoscopy: do novel agents bring a benefit?

Jörg Schmidbauer1, Michael Marberger.   

Abstract

PURPOSE OF REVIEW: In flat bladder cancer and carcinoma in situ, and in multifocal papillary cancer, some smaller lesions may be overlooked at cystoscopy. For 10 years fluorescence cystoscopy has been promoted to solve these problems without wider acceptance. New fluorophobes now promise better clinical applicability. RECENT
FINDINGS: In prospective multicenter studies fluorescence cystoscopy shows significant improvement in the detection of flat bladder cancer and carcinoma in situ. It also permits more reliable identification of all neoplastic lesions with multifocal tumors, hence more precise removal and as a consequence lower recurrence rates.
SUMMARY: New agents bring a significant benefit. Hexyl-aminolevulinate offers more rapid urothelial accumulation, better fluorescence contrast and less photobleaching than previously used fluorophobes. It is simple to use in everyday practice and has a favorable toxicity profile.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17762629     DOI: 10.1097/MOU.0b013e3282c8c73f

Source DB:  PubMed          Journal:  Curr Opin Urol        ISSN: 0963-0643            Impact factor:   2.309


  2 in total

Review 1.  Healthcare economics of bladder cancer: cost-enhancing and cost-reducing factors.

Authors:  Katia Noyes; Eric A Singer; Edward M Messing
Journal:  Curr Opin Urol       Date:  2008-09       Impact factor: 2.309

2.  Human bladder cancer diagnosis using Multiphoton microscopy.

Authors:  Sushmita Mukherjee; James S Wysock; Casey K Ng; Mohammed Akhtar; Sven Perner; Ming-Ming Lee; Mark A Rubin; Frederick R Maxfield; Watt W Webb; Douglas S Scherr
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2009
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.